ProShare Advisors LLC
- SEC CIK
- 0001357955
- Latest filing
- Aug 11, 2026
LCTX holding history
Lineage Cell Therapeutics, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 24,129
- Value
- $31.6K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 24,129 | $31.6K | <0.1% | +24,129 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −38,865−100.0% | Sold out | Holders |
| Q1 2025 | 38,865 | $17.6K | <0.1% | −2,741−6.6% | Reduced | Holders |
| Q4 2024 | 41,606 | $20.9K | <0.1% | +13,691+49.0% | Added | Holders |
| Q3 2024 | 27,915 | $25.3K | <0.1% | +10,141+57.1% | Added | Holders |
| Q2 2024 | 17,774 | $17.7K | <0.1% | −6,067−25.4% | Reduced | Holders |
| Q1 2024 | 23,841 | $35.3K | <0.1% | +1,877+8.5% | Added | Holders |
| Q4 2023 | 21,964 | $23.9K | <0.1% | +5,198+31.0% | Added | Holders |
| Q3 2023 | 16,766 | $19.8K | <0.1% | −18−0.1% | Reduced | Holders |
| Q2 2023 | 16,784 | $23.7K | <0.1% | +16,784 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −23,513−100.0% | Sold out | Holders |
| Q1 2022 | 23,513 | $36.0K | <0.1% | −3,884−14.2% | Reduced | Holders |
| Q4 2021 | 27,397 | $67.0K | <0.1% | +11,326+70.5% | Added | Holders |
| Q3 2021 | 16,071 | $40.0K | <0.1% | −15,388−48.9% | Reduced | Holders |
| Q2 2021 | 31,459 | $90.0K | <0.1% | +31,459 | New | Holders |